Biodegradable dextran-polylactide hydrogel networks: their swelling, morphology and the controlled release of indomethacin.
暂无分享,去创建一个
[1] T. Kissel,et al. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks , 1996 .
[2] N. Peppas,et al. Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. II. Diffusion and release studies , 1997 .
[3] Alan Smith,et al. Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration , 1986 .
[4] H. Allcock,et al. Synthesis and characterization of pH-sensitive poly(organophosphazene) hydrogels. , 1996, Biomaterials.
[5] R. Mashelkar,et al. Pendent chain linked delivery systems: I facile hydrolysis through anchimeric effect , 1996 .
[6] J. Kopeček,et al. Novel pH-sensitive hydrogels with adjustable swelling kinetics. , 1998, Biomaterials.
[7] Yi-you Huang,et al. Drug release from PLA/PEG microparticulates , 1997 .
[8] K. Nakamae,et al. A hydrophobically-modified bioadhesive polyelectrolyte hydrogel for drug delivery , 1997 .
[9] J. Israelachvili. Intermolecular and surface forces , 1985 .
[10] H. Brøndsted,et al. Dextran hydrogels for colon-specific drug delivery , 1995 .
[11] D. Cohn,et al. Poly(ether urethane) oligomers as poly(HEMA) crosslinkers , 1994 .
[12] A S Hoffman,et al. An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[13] Nicholas A. Peppas,et al. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .
[14] J. Gayet,et al. High water content BSA-PEG hydrogel for controlled release device: Evaluation of the drug release properties , 1996 .
[15] Y. Yokomizo,et al. The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers , 1996 .
[16] W. Hennink,et al. In vivo biocompatibility of dextran-based hydrogels. , 2000, Journal of biomedical materials research.
[17] J. Fox,et al. A novel skeletal drug delivery system using self-setting calcium phosphate cement VIII: the relationship between in vitro and in vivo drug release from indomethacin-containing cement , 1997 .
[18] K. Sugibayashi,et al. Release kinetics of indomethacin from pressure sensitive adhesive matrices , 1997 .
[19] N. Peppas,et al. Present and future applications of biomaterials in controlled drug delivery systems. , 1981, Biomaterials.
[20] Kinam Park,et al. Biodegradable Hydrogels for Drug Delivery , 1993 .
[21] H. Brøndsted,et al. Crosslinked dextran--a new capsule material for colon targeting of drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[22] C. Migliaresi,et al. A study on the in vitro degradation of poly(lactic acid). , 1994, Journal of biomaterials science. Polymer edition.
[23] Y. M. Lee,et al. Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[24] C. Nastruzzi,et al. Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors , 1996 .
[25] Y. Bae,et al. New biodegradable polymers for injectable drug delivery systems. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[26] Wim E. Hennink,et al. Controlled release of proteins from dextran hydrogels , 1996 .
[27] S. Lee,et al. Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[28] Seung Jin Lee,et al. Porous poly(l-lactide) membranes for guided tissue regeneration and controlled drug delivery: membrane fabrication and characterization , 1997 .
[29] Chih-Chang Chu,et al. Synthesis and characterization of biodegradable hydrophobic-hydrophilic hydrogel networks with a controlled swelling property , 2000 .
[30] Chih-Chang Chu,et al. Synthesis and characterization of biodegradable network hydrogels having both hydrophobic and hydrophilic components with controlled swelling behavior , 1999 .
[31] Y. Lee,et al. Albumin release from bioerodible hydrogels based on semi-interpenetrating polymer networks composed of poly(ϵ-caprolactone) and poly(ethylene glycol) macromer , 1997 .
[32] C. Chu,et al. Synthesis and characterization of dextran-maleic acid based hydrogel. , 1999, Journal of biomedical materials research.
[33] Wim E. Hennink,et al. Degradation and release behavior of dextran-based hydrogels , 1997 .
[34] O. Corrigan,et al. Investigation of the mechanisms governing the release of levamisole from poly-lactide-co-glycolide delivery systems , 1996 .
[35] A. Coombes,et al. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[36] Chong-Su Cho,et al. METHOXY POLY(ETHYLENE GLYCOL) AND CAPROLACTONE AMPHIPHILIC BLOCK CO POLYMERIC MICELLE CONTAINING INDOMETHACIN. II: MICELLE FORMATION AND DRUG RELEASE BEHAVIORS , 1998 .